The importance of this pathway in bone metabolism is demonstrated by the facts that pharmacologic blockage of RANKL is an effective treatment for osteoporosis [13], an inherited deficiency of RANK or RANKL causes osteopetrosis, and loss-of-function osteoprotegerin mutations cause juvenile Paget’s disease [14,15]. Here, TNFSF11 is linked to osteoporosis.